OA11012A - Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-nor-cycloprpaÄgÜtax-ène-13alpha-yle et son procédé de préparation - Google Patents
Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-nor-cycloprpaÄgÜtax-ène-13alpha-yle et son procédé de préparation Download PDFInfo
- Publication number
- OA11012A OA11012A OA9800085A OA9800085A OA11012A OA 11012 A OA11012 A OA 11012A OA 9800085 A OA9800085 A OA 9800085A OA 9800085 A OA9800085 A OA 9800085A OA 11012 A OA11012 A OA 11012A
- Authority
- OA
- OAPI
- Prior art keywords
- hydroxy
- oxo
- epoxy
- tert
- diacetoxy
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 4
- -1 (2r, 3s) -3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate dihydrate Chemical compound 0.000 title 1
- AMDOWEDYDFGDJI-IREPQIBFSA-N (2r,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid;dihydrate Chemical compound O.O.CC(C)(C)OC(=O)N[C@H]([C@@H](O)C(O)=O)C1=CC=CC=C1 AMDOWEDYDFGDJI-IREPQIBFSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- ZVAFCKLQJCZGAP-WDEREUQCSA-N (2r,3s)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H]([C@@H](O)C(O)=O)C1=CC=CC=C1 ZVAFCKLQJCZGAP-WDEREUQCSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 150000002576 ketones Chemical class 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000010511 deprotection reaction Methods 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 description 12
- 150000004683 dihydrates Chemical class 0.000 description 10
- 239000000843 powder Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 102100022298 Divergent paired-related homeobox Human genes 0.000 description 4
- 101000902412 Homo sapiens Divergent paired-related homeobox Proteins 0.000 description 4
- 238000001914 filtration Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001599 direct drying Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9514841A FR2742438B1 (fr) | 1995-12-14 | 1995-12-14 | Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy- 3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy- 5beta,2o-epoxy-1-hydroxy-9-oxo-19-nor-cyclopropa(g)tax-11- ene-13alpha-yle, et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11012A true OA11012A (fr) | 2003-03-06 |
Family
ID=9485512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9800085A OA11012A (fr) | 1995-12-14 | 1998-06-15 | Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-nor-cycloprpaÄgÜtax-ène-13alpha-yle et son procédé de préparation |
Country Status (37)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102851740A (zh) * | 2011-06-30 | 2013-01-02 | 复旦大学 | 一种氟代多烯紫杉醇晶体及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2698871B1 (fr) * | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-12-14 FR FR9514841A patent/FR2742438B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-12 UA UA98063068A patent/UA55401C2/uk unknown
- 1996-12-02 UY UY24387A patent/UY24387A1/es not_active IP Right Cessation
- 1996-12-04 TW TW085114946A patent/TW358093B/zh not_active IP Right Cessation
- 1996-12-04 ZA ZA9610200A patent/ZA9610200B/xx unknown
- 1996-12-09 DK DK96941720T patent/DK0876361T3/da active
- 1996-12-09 CN CNA2007101024535A patent/CN101113143A/zh active Pending
- 1996-12-09 PT PT96941720T patent/PT876361E/pt unknown
- 1996-12-09 SK SK790-98A patent/SK282512B6/sk not_active IP Right Cessation
- 1996-12-09 NZ NZ323964A patent/NZ323964A/xx not_active IP Right Cessation
- 1996-12-09 BR BR9611957A patent/BR9611957A/pt not_active IP Right Cessation
- 1996-12-09 IL IL12476696A patent/IL124766A/xx not_active IP Right Cessation
- 1996-12-09 AU AU11013/97A patent/AU713086C/en not_active Ceased
- 1996-12-09 CA CA002236545A patent/CA2236545C/fr not_active Expired - Fee Related
- 1996-12-09 EA EA199800452A patent/EA000668B1/ru not_active IP Right Cessation
- 1996-12-09 RO RO98-01069A patent/RO115880B1/ro unknown
- 1996-12-09 AT AT96941720T patent/ATE204573T1/de active
- 1996-12-09 KR KR10-1998-0704420A patent/KR100429330B1/ko not_active Expired - Fee Related
- 1996-12-09 TR TR1998/01087T patent/TR199801087T2/xx unknown
- 1996-12-09 JP JP52179097A patent/JP4059351B2/ja not_active Expired - Fee Related
- 1996-12-09 CZ CZ19981830A patent/CZ288998B6/cs not_active IP Right Cessation
- 1996-12-09 WO PCT/FR1996/001957 patent/WO1997021695A1/fr active IP Right Grant
- 1996-12-09 EP EP96941720A patent/EP0876361B1/fr not_active Expired - Lifetime
- 1996-12-09 PL PL96327451A patent/PL187613B1/pl not_active IP Right Cessation
- 1996-12-09 ES ES96941720T patent/ES2162123T3/es not_active Expired - Lifetime
- 1996-12-09 HU HU9904048A patent/HU224962B1/hu not_active IP Right Cessation
- 1996-12-09 DZ DZ960185A patent/DZ2140A1/fr active
- 1996-12-09 DE DE69614716T patent/DE69614716T2/de not_active Expired - Lifetime
- 1996-12-12 IN IN2788DE1996 patent/IN185809B/en unknown
- 1996-12-13 TN TNTNSN96157A patent/TNSN96157A1/fr unknown
- 1996-12-13 AR ARP960105668A patent/AR004380A1/es active IP Right Grant
- 1996-12-13 MY MYPI96005258A patent/MY115886A/en unknown
- 1996-12-13 CO CO96065734A patent/CO4810227A1/es unknown
-
1998
- 1998-06-04 NO NO19982561A patent/NO317356B1/no not_active IP Right Cessation
- 1998-06-12 BG BG102535A patent/BG63010B1/bg unknown
- 1998-06-15 OA OA9800085A patent/OA11012A/fr unknown
-
2001
- 2001-08-23 GR GR20010400773T patent/GR3036437T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0403351B2 (fr) | Procédé de préparation de l'acide ascorbique | |
| EP0770070B1 (fr) | Procede de preparation du trihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta,10beta-trihydroxy-9-oxo-tax-11-en-13alpha-yle | |
| FR2517302A1 (fr) | Esters et amides de 13 14-bisdehydroprostaglandines | |
| EP0593641A1 (fr) | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii. | |
| EP0452182A1 (fr) | Procédé d'obtention d'au moins une oléfine tertiaire par décomposition de l'éther correspondant | |
| EP0515541A1 (fr) | PROCEDE DE PREPARATION DE L'ACIDE CIS--g(b)-PHENYLGLYCIDIQUE-(2R,3R). | |
| FR2729666A1 (fr) | Procede de preparation du trihydrate du (2r, 3s)- benzoylamino-2-hydroxy-3-phenylpropionate de 4,10-diacetoxy- 2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxo- tax-11-en-13alpha-yle | |
| OA11012A (fr) | Dihydrate du (2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1-hydroxy-9-oxo-19-nor-cycloprpaÄgÜtax-ène-13alpha-yle et son procédé de préparation | |
| EP0102283B1 (fr) | Nouveau procédé de préparation de dérivés de la quinuclidine substitués en position 3 | |
| FR2696742A1 (fr) | Procédé de fabrication de formylimidazoles à partir de 4- ou 5-hydroxyméthylimidazoles. | |
| CA1080727A (en) | Preparation of epoxides | |
| JP2020083892A (ja) | ベラプロスト−３１４ｄ・一水和物結晶及びその製造方法 | |
| FR2464270A1 (fr) | Nouveaux derives d'amino-14 steroides, et procede pour leur preparation | |
| US6150541A (en) | 4,10-β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-19-norcyclopropa[g]t ax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate and its process of preparation | |
| EP0432029B1 (fr) | Procédé de préparation de synergistines | |
| EP0466583B1 (fr) | Procédé de préparation de la diméthyl-2,5 hydroxy-4 (2H)furanone-3 | |
| US7183420B2 (en) | Method for the preparation of 11(12)-pentadecen-15-olides | |
| MXPA98004604A (en) | Dihydrate (2r, 3s) -3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4, iobeta-diacetoxi-2alfa-benzoiloxi-5beta, 20-epoxi-1-hidroxi-9-oxo-19-nor- ciclopropa [g] tax-11- en-13alfa-ilo, and its preparation procedure | |
| CA1184208A (fr) | Procede de preparation d'halogenoacetals ethyleniques | |
| EP0060767B1 (fr) | Procédé de préparation de composés carbonylés delta-éthyléniques | |
| EP0145554A2 (fr) | Procédé de préparation de dérivés éthyléniques chlorés | |
| CN108250181A (zh) | 一种制备埃索美拉唑杂质d的方法 | |
| CH284719A (fr) | Procédé de préparation d'un acylamidodiol aromatique, nitré dans le noyau. | |
| CH294890A (fr) | Procédé pour la purification de la pénicilline. | |
| BE556145A (enrdf_load_stackoverflow) |